Can anyone shine some light on the recent talk of layoffs in the Neuromodulation sector for Abbott, Medtronic, and Nevro? Any merit to the rumors?
Earnings reports have highlighted some underlying challenges, seemingly for all players (ABT, MDT, BSX, and NVRO). Nuvectra filled for Chapter 11...